Integrative traditional Chinese medicine therapy reduces the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus

Journal of Ethnopharmacology

Volumn 191, Issue , 2016, Pages 324-330

  Lien, Angela Shin Yu ^a,b   Jiang, Yi Der ^c   Mou, Chih Hsin ^d   Sun, Mao Feng ^d,e   Gau, Bih Shya ^a   Yen, Hung Rong ^d,e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Astragalus membranaceus (Fisch.) Bunge; Astragalus membranaceus var. mongholicus (Bunge) P.K.Hsiao: diabetic ketoacidosis; National Health Insurance Research Database; Traditional Chinese medicine; Type 1 diabetes mellitus

Indexed keywords

HERBACEOUS AGENT; HUANG QI; LIU WEI DI HUANG WAN; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; ASTRAGALUS MEMBRANACEUS; CHINESE MEDICINE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; FEMALE; HEALTH CARE COST; HERBAL MEDICINE; HOSPITALIZATION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; REHMANNIA; TERMINAL DISEASE; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CLINICAL PRACTICE; DIABETES MELLITUS, TYPE 1; DRUG COST; DRUG EFFECTS; ECONOMICS; GLUCOSE BLOOD LEVEL; HOSPITAL COST; HOSPITAL EMERGENCY SERVICE; INTEGRATED HEALTH CARE SYSTEM; METABOLISM; REGISTER; TAIWAN; TIME FACTOR; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DELIVERY OF HEALTH CARE, INTEGRATED; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; DRUG COSTS; DRUG PRESCRIPTIONS; DRUGS, CHINESE HERBAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MEDICINE, CHINESE TRADITIONAL; PRACTICE PATTERNS, PHYSICIANS'; REGISTRIES; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84976875235     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2016.06.051     Document Type: Article

References (41)

1. Barker, A., Lauria, A., Schloot, N., Hosszufalusi, N., Ludvigsson, J., Mathieu, C., Mauricio, D., Nordwall, M., Van der Schueren, B., Mandrup-Poulsen, T., Scherbaum, W.A., Weets, I., Gorus, F.K., Wareham, N., Leslie, R.D., Pozzilli, P., Age-dependent decline of beta-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study. Diabetes Obes. Metab. 16 (2014), 262–267.
2. Bensky, D., Clavey, S., Stoger, E., Chinese Herbal Medicine: Materia Medica. 3rd ed., 2004, Eastland Press, Inc., Seatle, WA, USA.
3. Chan, K., Shaw, D., Simmonds, M.S., Leon, C.J., Xu, Q., Lu, A., Sutherland, I., Ignatova, S., Zhu, Y.P., Verpoorte, R., Williamson, E.M., Duez, P., Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. J. Ethnopharmacol. 140 (2012), 469–475.
4. Chien, S.C., Larson, E., Nakamura, N., Lin, S.J., Self-care problems of adolescents with type 1 diabetes in southern Taiwan. J. Pediatr. Nurs. 22 (2007), 404–409.
5. Ching, S.M., Zakaria, Z.A., Paimin, F., Jalalian, M., Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC Complement. Altern. Med., 13, 2013, 148.
6. Dannemann, K., Hecker, W., Haberland, H., Herbst, A., Galler, A., Schäfer, T., Brähler, E., Kiess, W., Kapellen, T.M., Use of complementary and alternative medicine in children with type 1 diabetes mellitus–prevalence, patterns of use, and costs. Pediatr. Diabetes 9 (2008), 228–235.
7. Fabian, E., Töscher, S., Elmadfa, I., Pieber, T.R., Use of complementary and alternative medicine supplements in patients with diabetes mellitus. Ann. Nutr. Metab. 58 (2011), 101–108.
8. Fleischer, T., Chang, T.T., Chiang, J.H., Chang, C.M., Hsieh, C.Y., Yen, H.R., Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population-based cohort study. Cancer Med. 5 (2016), 640–648.
9. Fu, P., Liu, F., Integrated management of diabetic kidney disease: from prevention to treatment, from biomedicine to translation medicine. J. Sichuan Univ. Med. Sci. Ed. 43 (2012), 409–413.
10. Gan, M.J., Albanese-O'Neill, A., Haller, M.J., Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research. Curr. Probl. Pediatr. Adolesc. Health Care 42 (2012), 269–291.
11. Garrow, D., Egede, L.E., Association between complementary and alternative medicine use, preventive care practices, and use of conventional medical services among adults with diabetes. Diabetes Care 29 (2006), 15–19.
12. Ha do, T., Trung, T.N., Hien, T.T., Dao, T.T., Yim, N., Ngoc, T.M., Oh, W.K., Bae, K., Selected compounds derived from Moutan Cortex stimulated glucose uptake and glycogen synthesis via AMPK activation in human HepG2 cells. J. Ethnopharmacol. 131 (2010), 417–424.
13. Haliloglu, B., İşgüven, P., Yıldız, M., Arslanoğlu, İ., Ergüven, M., Complementary and alternative medicine in children with type 1 diabetes mellitus. J. Clin. Res. Pediatr. Endocrinol., 3, 2011, 139.
14. Hong, Y.J., Kim, N., Lee, K., Hee Sonn, C., Eun Lee, J., Tae Kim, S., Ho Baeg, I., Lee, K.M., Korean red ginseng (Panax ginseng) ameliorates type 1 diabetes and restores immune cell compartments. J. Ethnopharmacol. 144 (2012), 225–233.
15. Hsing, A.W., Ioannidis, J.P., Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern. Med. 175 (2015), 1527–1529.
16. Hsu, P.C., Tsai, Y.T., Lai, J.N., Wu, C.T., Lin, S.K., Huang, C.Y., Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study. J. Ethnopharmacol. 156 (2014), 358–364.
17. Hu, J., Li, Y.L., Li, Z.L., Li, H., Zhou, X.X., Qiu, P.C., Yang, Q., Wang, S.W., Chronic supplementation of paeonol combined with danshensu for the improvement of vascular reactivity in the cerebral basilar artery of diabetic rats. Int. J. Mol. Sci. 13 (2012), 14565–14578.
18. Huang, C.Y., Tsai, Y.T., Lai, J.N., Hsu, F.L., Prescription pattern of chinese herbal products for diabetes mellitus in taiwan: a population-based study. Evid.-Based Complement. Altern. Med.: eCAM, 2013, 2013, 201329.
19. Huang, M.C., Pai, F.T., Lin, C.C., Chang, C.M., Chang, H.H., Lee, Y.C., Sun, M.F., Yen, H.R., Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: a nationwide population-based study. J. Ethnopharmacol. 176 (2015), 9–16.
20. Huang, T.P., Liu, P.H., Lien, A.S., Yang, S.L., Chang, H.H., Yen, H.R., A nationwide population-based study of traditional Chinese medicine usage in children in Taiwan. Complement. Ther. Med. 22 (2014), 500–510.
21. Hung, J.Y., Chiou, C.J., Chang, H.Y., Relationships between medical beliefs of superiority of Chinese or Western medicine, medical behaviours and glycaemic control in diabetic outpatients in Taiwan. Health Soc. Care Community 20 (2012), 80–86.
22. International Diabetes Federation, I., 2013. International Diabetes Federation. IDF Diabetes Atlas, 6th ed.
23. Jiang, Y.-D., Chang, C.-H., Tai, T.-Y., Chen, J.-F., Chuang, L.-M., Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000–2009 Nationwide Health Insurance database. J. Formosan Med. Assoc., 2012.
24. Kim, S., Shin, S., Hyun, B., Kong, H., Han, S., Lee, A., Lee, S., Kim, K., Immunomodulatory effects of dioscoreae rhizome against inflammation through suppressed production of cytokines via inhibition of the NF-kappaB pathway. Immune Netw. 12 (2012), 181–188.
25. Kim, T.H., Choi, T.Y., Shin, B.C., Lee, M.S., Moxibustion for managing type 2 diabetes mellitus: a systematic review. Chin. J. Integr. Med. 17 (2011), 575–579.
26. Lee, A.L., Chen, B.C., Mou, C.H., Sun, M.F., Yen, H.R., Association of traditional Chinese medicine therapy and the risk of vascular complications in patients with type II diabetes mellitus: a nationwide, retrospective, Taiwanese-registry, cohort study. Medicine, 95, 2016, e2536.
27. Lee, H.J., Lee, Y.H., Park, S.K., Kang, E.S., Kim, H.J., Lee, Y.C., Choi, C.S., Park, S.E., Ahn, C.W., Cha, B.S., Lee, K.W., Kim, K.S., Lim, S.K., Lee, H.C., Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. Metab.: Clin. Exp. 58 (2009), 1170–1177.
28. Li, Y.J., Xu, H.X., Research progress on anti-diabetic Chinese medicines. Zhong yao cai = Zhongyaocai = J. Chin. Med. Mater. 29 (2006), 621–624.
29. Lin, W.-H., Wang, M.-C., Wang, W.-M., Yang, D.-C., Lam, C.-F., Roan, J.-N., Li, C.-Y., Incidence of and mortality from type I diabetes in Taiwan from 1999 through 2010: a nationwide cohort study. PloS One, 9, 2014, e86172.
30. Lu, C.L., Shen, H.N., Chen, H.F., Li, C.Y., Epidemiology of childhood type 1 diabetes in Taiwan, 2003 to 2008. Diabet. Med. 31 (2014), 666–673.
31. Poon, T.Y., Ong, K.L., Cheung, B.M., Review of the effects of the traditional Chinese medicine Rehmannia Six Formula on diabetes mellitus and its complications. J. Diabetes 3 (2011), 184–200.
32. Scheid, V., Bensky, D., Ellis, A., Barolet, R., Chinese Herbal Medicine: Formulas & Strategies. 2009, Eastland Press Inc., Seatle, WA, USA 2nd Ed.
33. van Wietmarschen, H.A., van der Greef, J., Schroen, Y., Wang, M., Evaluation of symptom, clinical chemistry and metabolomics profiles during Rehmannia six formula (R6) treatment: an integrated and personalized data analysis approach. J. Ethnopharmacol. 150 (2013), 851–859.
34. Wang, Z.S., Xiong, F., Xie, X.H., Chen, D., Pan, J.H., Cheng, L., Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress. BMC Nephrology, 16, 2015, 44.
35. Wong, K.L., Wong, R.N., Zhang, L., Liu, W.K., Ng, T.B., Shaw, P.C., Kwok, P.C., Lai, Y.M., Zhang, Z.J., Zhang, Y., Tong, Y., Cheung, H.P., Lu, J., Sze, S.C., Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential. Chin. Med., 9, 2014, 19.
36. Xie, W., Du, L., Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes. Metab. 13 (2011), 289–301.
37. Xu, A., Wang, H., Hoo, R.L., Sweeney, G., Vanhoutte, P.M., Wang, Y., Wu, D., Chu, W., Qin, G., Lam, K.S., Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology 150 (2009), 625–633.
38. Yeh, G.Y., Eisenberg, D.M., Kaptchuk, T.J., Phillips, R.S., Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26 (2003), 1277–1294.
39. Yen, H.R., Huang, T.P., Sun, M.F., Chinese medicine usage in Taiwan: a nationwide population-based study. RCHM Journal 10 (2013), 21–27.
40. Zhang, M.H., Feng, L., Zhu, M.M., Gu, J.F., Jiang, J., Cheng, X.D., Ding, S.M., Wu, C., Jia, X.B., The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and high-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats. J. Ethnopharmacol. 151 (2014), 591–600.
41. Zhang, T.T., Jiang, J.G., Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications. Expert Opin. Invest. drugs 21 (2012), 1625–1642.